Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $921 | $908 | $1,015 | $2,080 |
| Dep. & Amort. | $493 | $439 | $437 | $408 |
| Deferred Tax | $13 | -$49 | $1 | -$57 |
| Stock-Based Comp. | $88 | $77 | $77 | $79 |
| Change in WC | -$201 | -$145 | $119 | $87 |
| Other Non-Cash | $20 | $42 | $69 | -$364 |
| Operating Cash Flow | $1,334 | $1,272 | $1,718 | $2,233 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$425 | -$408 | -$404 | -$403 |
| Net Acquisitions | -$2,164 | -$611 | -$144 | $424 |
| Inv. Purchases | $0 | $0 | -$5 | -$3 |
| Inv. Sales/Matur. | $0 | $0 | $5 | $403 |
| Other Inv. Act. | $41 | -$42 | $5 | -$400 |
| Investing Cash Flow | -$2,548 | -$1,061 | -$543 | $21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,543 | $748 | -$2 | -$2 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$151 | -$275 | -$1,408 | -$2,199 |
| Dividends Paid | -$331 | -$314 | -$305 | -$309 |
| Other Fin. Act. | $23 | $1 | -$17 | -$30 |
| Financing Cash Flow | $1,084 | $160 | -$1,732 | -$2,540 |
| Forex Effect | -$7 | $0 | $0 | $0 |
| Net Chg. in Cash | -$137 | $371 | -$557 | -$286 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $686 | $315 | $872 | $1,158 |
| End Cash | $549 | $686 | $315 | $872 |
| Free Cash Flow | $909 | $864 | $1,314 | $1,830 |